Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
2301studies shown
Showing 625-636 of 2,301
Drug study icon
TerminatedNCT05518149

Aticaprant in Adult and Elderly people with Major Depressive Disorder (MDD)

This study was terminated in the United States, in Australia, in France, .... It is testing aticaprant for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugA study involving a medication or substance.From 18 Years to 74 Years
Countries
United States, Australia, France, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Device study icon
Active Not RecruitingNCT04106466

DBS for TRD With the Medtronic Summit RC+S

This observational study is following people with depression or Treatment Resistant Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 25 Years to 70 Years
Countries
United States
Sponsor
Helen Mayberg, MD
Condition
Depression
Drug study icon
TerminatedNCT04634669

Safety study of AXS-05 in Depression

This study was terminated in the United States. It is testing AXS-05 for Depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Axsome Therapeutics, Inc.
Condition
Depression
Drug study icon
Active Not RecruitingNCT06308653

Psilocybin for Major Depressive Disorder (MDD)

This study is comparing Psilocybin 25 mg with placebo for people with major depression. Participants receive Psilocybin 25 mg or placebo and complete study visits and assessments.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugOver 18 Years
Countries
United States
Sponsor
Usona Institute
Condition
Depression
Device study icon
CompletedNCT03014544

Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery for depression

This study is completed in the United States. It is testing Performance Validity and Test-Retest Reliability of a Computer-Administered Cognitive Test Battery for depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDeviceFrom 18 Years to 59 Years
Countries
United States
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Drug study icon
Active Not RecruitingNCT04433858

Safety and Efficacy of Psilocybin for treatment-resistant depression

This study is active but not recruiting in the United States. It is testing safety and Efficacy of Psilocybin for treatment-resistant depression.

In United States
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Sheppard Pratt Health System
Condition
Depression
Drug study icon
CompletedNCT05615948

Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand whether a therapy or guided support program can make support easier to access outside standard clinic visits.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionDrugFrom 18 Years to 89 Years
Countries
United States
Sponsor
Theresa Jacob, PhD, MPH
Condition
Depression
Behavioral study icon
CompletedNCT06025838

Positive Feedback vs. No-Feedback Games for Behavioral Change

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online
Why is this study shown?

This study is directly about Depression.

DepressionBehavioralFrom 18 Years to 34 Years
Countries
United States
Sponsor
Bard College
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.